Abstract
A series of alkyl 2-Arylhydrazinylidene-3-oxo-3-polyfluoroalkylpropionates was synthesized and their inhibitory activity with respect to porcine liver carboxylesterase (CaE, EC 3.1.1.1), human erythrocyte acetylcholinesterase (AChE, EC 3.1.1.7), and horse serum butyrylcholinesterase (BChE, EC 3.1.1.8) was studied. The molecular docking method was used to study the binding mode of the compounds in the active site of CaE. It was found that compounds containing the trifluoromethyl group in the third position of carbonyl chain are highly effective and selective inhibitors of CaE with nanomolar IC50 values, which agrees well with the results of molecular docking.
Similar content being viewed by others
References
Imai, T., Drug. Metab. Pharmacokinet., 2006, vol. 21, no. 3, pp. 173–185.
Laizure, S.C., Herring, V., Hu, Z., Witbrodt, K., and Parker, R.B., Pharmacotherapy, 2013, vol. 33, no. 2, pp. 210–222.
Hatfield, M.J. and Potter, P.M., Expert Opin. Ther. Pat., 2011, vol. 21, no. 8, pp. 1159–1171.
Bachurin, S.O., Med. Res. Rev., 2003, vol. 23, no. 1, pp. 48–88.
Tsvetkov, E.N., Degtyarev, A.N., Makhaeva, G.F., Bovin, A.N., and Yankovskaya, V.L., Inventor’s certificate no. 1187444, priority of 11.03.1984, registered 22.06.1985.
Rudakova, E.V., Makhaeva, G.F., Galenko, T.G., Aksinenko, A.Yu., Sokolov, V.B., and Martynov, I.V., Dokl. Biochem. Biophys., 2013, vol. 449, pp. 87–89.
Mukhamadieva, G.R., Boltneva, N.P., Galenko, T.G., Sokolov, V.B., Epishina, T.A., and Makhaeva, G.F., Khim.-Farm. Zh., 2012, no. 8, pp. 3–6.
Mitchell, A. and Nonhebel, D.C., Tetrahedron, 1979, vol. 35, no. 17, pp. 2013–2019.
Burgart, Ya.V., Fokin, A.S., Kuzueva, O.G., Chupakhin, O.N., and Saloutin, V.I., J. Fluorine Chem., 1998, vol. 92, no. 2, pp. 101–108.
Khudina, O.G., Burgart, Ya.V., Shchegol’kov, E.V., Saloutin, V.I., Kazheva, O.N., Chekhlov, A.N., and D’yachenko, O.A., Zh. Org. Khim., 2009, vol. 45, no. 6, pp. 819–827.
Bencharit, S., Edwards, C.C., Morton, C.L., HowardWilliams, E.L., Kuhn, P., Potter, P.M., and Redinbo, M.R., J. Mol. Biol., 2006, vol. 363, no. 1, pp. 201–214.
Masson, P., Lushchekina, S., Schopfer, L.M., and Lockridge, O., Biochem. J., 2013, vol. 454, no. 3, pp. 387–399.
Schmidt, M.W., Baldridge, K.K., Boatz, J.A., Elbert, S.T., Gordon, M.S., et al., J. Comput. Chem., 1993, vol. 14, no. 11, pp. 1347–1363.
Lushchekina, S.V., Polomskikh, V.S., Varfolomeev, S.D., and Masson, P., Izv. Akad. Nauk, Ser. Khim., 2013, vol. 62, no. 11, pp. 2527–2537.
Satoh, T. and Hosokawa, M., Annu. Rev. Pharmacol. Toxicol., 1998, vol. 38, pp. 257–288.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © N.P. Boltneva, G.F. Makhaeva, N.V. Kovaleva, S.V. Lushchekina, Ya.V. Burgart, E.V. Shchegol’kov, V.I. Saloutin, O.N. Chupakhin, 2015, published in Doklady Akademii Nauk, 2015, Vol. 465, No. 3, pp. 367–371.
Rights and permissions
About this article
Cite this article
Boltneva, N.P., Makhaeva, G.F., Kovaleva, N.V. et al. Alkyl 2-arylhydrazinylidene-3-oxo-3-polyfluoroalkylpropionates as new effective and selective inhibitors of carboxylesterase. Dokl Biochem Biophys 465, 381–385 (2015). https://doi.org/10.1134/S1607672915060101
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1607672915060101